[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100468706":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":33,"responsibleParty":170,"collaborators":172,"id":175,"slug":176,"hasResults":177,"nctId":178,"briefTitle":179,"officialTitle":179,"acronym":180,"eligibilityCriteria":181,"healthyVolunteers":177,"sex":182,"minAge":183,"maxAge":184,"enrollmentInfo":185,"targetDuration":18,"studyType":188,"phases":189,"briefSummary":191,"conditions":192,"keywords":18,"overallStatus":36,"whyStopped":18,"lastUpdateSubmitDate":194,"lastUpdatePostDateStruct":195,"startDateStruct":198,"completionDateStruct":200,"leadSponsor":202,"locationsCount":203},{"fullName":5,"class":6},"Urotronic Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Optilume Urethral DCB","EXPERIMENTAL","The Optilume Drug Coated Balloon (DCB) is a guidewire compatible catheter with a tapered atraumatic tip. The distal end of the catheter has an inflatable balloon coated with a proprietary coating containing the drug paclitaxel that facilitates the drug's transfer to the urethral wall upon inflation.",[13],"Combination Product: Optilume Urethral DCB",[15],{"type":16,"name":9,"description":11,"armGroupLabels":17,"otherNames":18},"COMBINATION_PRODUCT",[9],null,[20],{"name":21,"affiliation":22,"role":23},"Karl Coutinho, MD","New Jersey Urology","PRINCIPAL_INVESTIGATOR",[25,29],{"name":26,"role":27,"phone":18,"phoneExt":18,"email":28},"Brenda Johnson, MS","CONTACT","bjohnson@laborie.com",{"name":30,"role":27,"phone":31,"phoneExt":18,"email":32},"Reem Ennenga","612-747-4183","rennenga@laborie.com",[34,57,76,94,105,115,130,140,155],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Arkansas Urology","RECRUITING","Little Rock","Arkansas","72211","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-92.28959,34.74648,{"lat":46,"lon":45},[49,54],{"name":50,"role":27,"phone":51,"phoneExt":52,"email":53},"Katie O'Brien","501-219-8900","2002","katie@arkansasurology.com",{"name":55,"role":27,"phone":51,"phoneExt":52,"email":56},"Sarah Lilly","slilly@arkansasurology.com",{"facility":58,"status":36,"city":59,"state":60,"zip":61,"country":40,"countryCode":41,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Orlando Health","Orlando","Florida","32806",{"type":43,"coordinates":63},[64,65],-81.37924,28.53834,{"lat":65,"lon":64},[68,72],{"name":69,"role":27,"phone":70,"phoneExt":18,"email":71},"Tatyana Nixon","321-843-8343","tatyana.nixon@orlandohealth.com",{"name":73,"role":27,"phone":74,"phoneExt":18,"email":75},"Briana Jackson","321-841-7147","briana.jackson@orlandohealth.com",{"facility":77,"status":36,"city":78,"state":60,"zip":79,"country":40,"countryCode":41,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Florida Urology","Tampa","33615",{"type":43,"coordinates":81},[82,83],-82.45843,27.94752,{"lat":83,"lon":82},[86,90],{"name":87,"role":27,"phone":88,"phoneExt":18,"email":89},"Jodi S","813-431-4913","jodi@gulfcoastcta.com",{"name":91,"role":27,"phone":92,"phoneExt":18,"email":93},"Linda Seibert","239-223-4488","linda@gulfcoastcta.com",{"facility":95,"status":96,"city":97,"state":98,"zip":99,"country":40,"countryCode":41,"cosmosGeoPoint":100,"geoPoint":104,"contacts":18},"Regional Urology","COMPLETED","Shreveport","Louisiana","71106",{"type":43,"coordinates":101},[102,103],-93.75018,32.52515,{"lat":103,"lon":102},{"facility":106,"status":96,"city":107,"state":108,"zip":109,"country":40,"countryCode":41,"cosmosGeoPoint":110,"geoPoint":114,"contacts":18},"Chesapeake","Hanover","Maryland","21076",{"type":43,"coordinates":111},[112,113],-76.72414,39.19289,{"lat":113,"lon":112},{"facility":116,"status":36,"city":117,"state":118,"zip":119,"country":40,"countryCode":41,"cosmosGeoPoint":120,"geoPoint":124,"contacts":125},"Freedman Urology","Las Vegas","Nevada","89144",{"type":43,"coordinates":121},[122,123],-115.13722,36.17497,{"lat":123,"lon":122},[126],{"name":127,"role":27,"phone":128,"phoneExt":18,"email":129},"Danielle Freedman","702-732-0282","drfreedman@msn.com",{"facility":131,"status":96,"city":132,"state":133,"zip":134,"country":40,"countryCode":41,"cosmosGeoPoint":135,"geoPoint":139,"contacts":18},"New Jersey Urolgy","Millburn","New Jersey","07041",{"type":43,"coordinates":136},[137,138],-74.30404,40.72482,{"lat":138,"lon":137},{"facility":141,"status":36,"city":142,"state":143,"zip":144,"country":40,"countryCode":41,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Western New York","Cheektowaga","New York","14225",{"type":43,"coordinates":146},[147,148],-78.75475,42.90339,{"lat":148,"lon":147},[151],{"name":152,"role":27,"phone":153,"phoneExt":18,"email":154},"Amy Bondanelle, MD","716-844-5559","abondanella@wnyurology.com",{"facility":156,"status":36,"city":157,"state":158,"zip":159,"country":40,"countryCode":41,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"Urology Clinics of North Texas","Dallas","Texas","75231",{"type":43,"coordinates":161},[162,163],-96.80667,32.78306,{"lat":163,"lon":162},[166],{"name":167,"role":27,"phone":168,"phoneExt":18,"email":169},"Holly Baril","214-580-1482","hbaril@urologyclinics.com",{"type":171,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[173],{"name":174,"class":6},"Laborie Medical Technologies Inc.","100468706","phase-4-optilume-post-approval-clinical-evaluation-of-andrology-parameters-100468706",false,"NCT05383274","Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters","STREAM","Inclusion Criteria:\n\n1. Male subjects between 22 and 65 years of age\n2. Subject diagnosed with a stricture in the anterior urethra that is able to be treated with the Optilume Urethral DCB in accordance with the approved Instructions for Use\n3. Subject is willing to provide written informed consent and comply with study required follow-up assessments\n4. Subject able to provide viable semen samples and baseline semen quality characteristics are above reference values based on below criteria (average of 2 samples):\n\n   1. total sperm ≥39 million\n   2. sperm concentration ≥15 million\u002FmL\n   3. total motility ≥40%\n   4. progressive motility ≥32%\n   5. morphology ≥4%\n\nExclusion Criteria:\n\n1. Subjects with a known hypersensitivity to paclitaxel or structurally related compounds\n2. Subjects with a history of vasectomy or other condition that may inhibit semen\u002Fsperm production or ejaculatory function\n3. Subjects currently taking 5-alpha reductase inhibitors, alpha-blockers, selective serotonin reuptake inhibitors, or hormone replacement therapy without appropriate washout\n4. Subject is unwilling to abstain or utilize a condom for 30 days after the procedure\n5. Subject is unwilling to utilize highly effective contraception for 6 months after the procedure if partner is of childbearing potential\n6. History of cancer in any body system that is not considered in complete remission","MALE","22 Years","65 Years",{"count":186,"type":187},34,"ESTIMATED","INTERVENTIONAL",[190],"PHASE4","Single-arm, prospective study assessing semen quality after treatment with the Optilume Urethral DCB in men between 22 and 65 years of age.",[193],"Urethral Stricture","2026-04-27",{"date":196,"type":197},"2026-04-28","ACTUAL",{"date":199,"type":197},"2022-02-14",{"date":201,"type":187},"2026-12-30",{"name":5,"class":6},9]